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g）および Hartley 系雄性モルモット（体重約280 
g）各12匹を，九動（株）より購入して用いた。こ
れらの実験動物を１群３匹とし，未処理群，PB 前
処理群，MC 前処理群および DEX 前処理群の４群
に分けた。PB 前処理群は，PB を生理食塩水に溶解
し80mg/kg/day の用量で，MC 前処理群は，MC を
コーン油に溶解し20mg/kg/day の用量で，いずれ
も３日間腹腔内投与した。DEX 前処理群は，DEX












リトロンホモジナイザー PT-K（Kinematica AG 製）
を用いた。一方，肝9,000× ɡ 上清は，肝を摘出
後，生理食塩水で灌流し，0.25mM ショ糖 -0.1mM 




　0.28mM NBL は，NADPH 生 成 系 （0.33mM 
NADP，5mM G-6-P，G-6-PD 1.0unit），6mM 
MgCl2および各動物の小腸，腎および肝9,000×ɡ








製 ）； カ ラ ム，LiChrospher 100: RP-18（250×
4 mm i.d.，5μm 粒径，Merck 製）；移動相，50％ 
acetonitrile - 0.01M ギ酸；流速，1mL/min；検出
波長，340nm。
５．小腸および腎9,000× g 上清中 CYP1A1の検出





学製），二次抗体（ウサギ抗ヤギ IgG-horse radish 

















































































































１．肝9,000× g 上清による NBL 代謝













２．小腸9,000× g 上清による NBL 代謝
　ラットおよびモルモット小腸9,000× ɡ 上清によ
る NBL 代謝に及ぼす P450誘導剤の影響を調べた。
小腸の代謝活性は肝のそれよりもかなり低いものと
仮定し，インキュベーション時間を90分間とした。








は4'-OH 体が1.8 nmol/60min/mg protein と最も多
く生成されたが，MC 前処理群では1.7倍に増加し










































N.D.  N.D. 
Fig. 2　Metabolism of NBL by liver 9,000×g 
supernatants from untreated rats.
N.D., not detected.   Each bar represents 
mean ± S.D. of three rats.
３．腎9,000× g 上清による NBL 代謝
　次に，ラット腎およびモルモット腎9,000×ɡ 上
















同 様 に， ５ 種 類（4'-OH 体，7-OH 体，6-OH 体，
3',4'-diOH 体および6,7-diOH 体）がすべて生成さ





































































N.D.      N.D.        N.D.        N.D.     N.D. 
* 
                       N.D.     N.D. 
B) Guinea pig 
A) Rat 
Fig. 3　Metabolism of NBL by small intestine 9,000×g supernatants from 
untreated, PB-treated, MC-treated and DEX-treated rats (A) and 
guinea pigs (B).
N.D., not detected.   Each bar represents mean ± S.D. of three 
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      N.D.        N.D.        N.D.     N.D. 
Fig. 4　Metabolism of NBL by kidney 9,000×g supernatants from 
untreated, PB-treated, MC-treated and DEX-treated rats (A) and 
guinea pigs (B).
N.D., not detected.  Each bar represents mean ± S.D. of three 
animals.   *Significantly different from untreated animals, p<0.05.
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OH 体，7-OH 体および6-OH 体）が生成された。ま
た，ラット腎では，4'-OH 体の生成が観察された
のに対し，モルモット腎では，３種類の代謝物（4'-



























(A) Small intestine (B) Kidney   
Rat  Guinea pig   Rat  Guinea pig 
C  P  M  D C  P  M  D C  P  M  D   C  P  M  D 









 (Fig. 5) 
 
 
Fig. 5　Immunostaining of small intestine and kidney 9,000×g supernatants from rats and 
guinea pigs against rat hepatic CYP1A1.










































１．小腸と腎9,000× ɡ 上清の NBL 代謝活性をラッ
トとモルモットで比較した。また，チトクロム
P450誘導剤の効果も調べた。
２．小腸9,000× ɡ 上清による NBL 代謝をみたとこ
ろ，ラットで全く代謝されなかったが，モルモッ
トでは4'-OH 体，7-OH 体および6-OH 体が生成
された。





















　Nobiletin（NBL）, a polymethoxyflavone present 
abundantly in the peels of citrus fruits, has 
been shown to be anti-inflammatory and anti-
carcinogenic. Our recent studies have elucidated 
using liver microsomes and cytochrome P450 
（P450）isoforms from animals and human that 
NBL is metabolized to three mono-demethylated 
metabolites（4'-OH-, 7-OH- and 6-OH-NBL）and 
two di-demethylated metabolites（3',4'-diOH- 
and 6,7-diOH-NBL）and that CYP1A and CYP3A 
enzymes are responsible for NBL metabolism.  In 
this study, we examined the in vitro metabolism of 
NBL using 9,000×ɡ  supernatants of extrahepatic 
tissues such as small intestine and kidney from 
rats and guinea pigs, and also the effect of P450 
inducers, phenobarbital （PB）, 3-methylcholantrene 
（MC）and dexamethasone（DEX）on NBL 
metabolism.   Rat small intestine 9,000×ɡ  
supernatants had no activity to metabolize NBL. 
In contrast, guinea pig small intestine 9,000×ɡ  
supernatants produced 4'-OH-, 7-OH- and 6-OH-
NBL and their formation were slightly increased 
by MC-pretreatment.   On the other hand, guinea 
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pig kidney 9000×ɡ  supernatants produced 
five metabolites in the same manner as liver 
microsomes, and both 4'-OH- and 6,7-diOH-NBL 
were markedly increased by MC-pretreatment. 
Pretreatment of PB and DEX did not almost 
affect NBL metabolism.   Western blotting and 
immunostaining showed the marked increase of 
CYP1A1 protein in both animal kidneys.   These 
results suggest that extrahepatic tissues such as 
small intestine and kidney could metabolize NBL 
with lower activities than liver, and that kidney 
CYP1A1 plays an important role in NBL metabolism 
in both animals, especially in guinea pigs.
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